Published on
Nov 9, 2026
Eli Lilly and Company (LLY) Stock: Surges 4.50% as Foundayo Delivers Positive Phase 3 Sleep Apnea Results
TLDR LLY stock jumped 4.50% to $1,414.93 following positive Foundayo Phase 3 results. Foundayo cut sleep apnea events by 43.8% among participants without PAP therapy. Patients using PAP therapy saw a 27.5% decline in sleep apnea breathing events. Foundayo …
Source:
Blockonomi
-
Neutral
